Title : Pharmacovigilance study of the association between dipeptidyl peptidase-4 inhibitors and angioedema using the FDA Adverse Event Reporting System (FAERS) - Ohyama_2022_Sci.Rep_12_13122 |
Author(s) : Ohyama K , Shindo J , Takahashi T , Takeuchi H , Hori Y |
Ref : Sci Rep , 12 :13122 , 2022 |
Abstract : Ohyama_2022_Sci.Rep_12_13122 |
ESTHER : Ohyama_2022_Sci.Rep_12_13122 |
PubMedSearch : Ohyama_2022_Sci.Rep_12_13122 |
PubMedID: 35907939 |
Ohyama K, Shindo J, Takahashi T, Takeuchi H, Hori Y (2022)
Pharmacovigilance study of the association between dipeptidyl peptidase-4 inhibitors and angioedema using the FDA Adverse Event Reporting System (FAERS)
Sci Rep
12 :13122
Ohyama K, Shindo J, Takahashi T, Takeuchi H, Hori Y (2022)
Sci Rep
12 :13122